Cancer New Study
I read that esophageal cancer is an increasingly common disease and represents 1 percent of new cancers diagnosed in the United States. Though it may be common, but an easy to treat cancer it is not. What has not changed dramatically since 2000, is its survivability. Esophageal cancer articles I read in 2000 seem to contain the same outcome in 2017. Within five years of an esophageal cancer diagnosis, four out of five patients do not survive. While new cases of esophageal cancer are among the fastest growing cancers, treatments given today are similar to treatments offered in 2000 and often have the same failure to help results.
Before my husband’s diagnosis, I had never heard of cancer of the esophagus. I know from experience the uphill battle esophageal cancer demands are not for lack of outstanding oncologists, gastrointestinal and thoracic surgeons, and their comprehensive teams. Simply said, this cancer is the beast.
But hope lies in physicians, and scientist’s dedication to understanding esophageal cancer’s molecular character thereby raising new possibilities discover new treatments to give folks afflicted with esophageal cancer a better and longer life.
Next Post: What I learned from The Cancer Genome Atlas and why that matters for hope on the horizon.
Photo Credit: Stefan Zwahlen